logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

WELL LINK SEC (08350) spending 140,800 Hong Kong dollars on April 1 to repurchase 536,000 shares.

date
17:24 01/04/2026
avatar
GMT Eight
Liqiao Securities Holdings (08350) announced that on April 1, 2026, the company repurchased 536,000 shares at a cost of HK$140,800.
WELL LINK SEC (08350) announced on April 1, 2026, that the company will spend 140,800 Hong Kong dollars to repurchase 536,000 shares.
Related Articles
HK Stock
NEWAY GROUP (00055): Zhang Yushan appointed as the new company secretary.
HK Stock
GLORIOUS PPT H(00845): Property units selling and delivering total construction area exceeding 70,000 square meters in 2025.
HK Stock
SINOMAB BIO-B (03681): The first patient in China with atopic dermatitis completes Phase 2 clinical trial of SM17 treatment.
NEWAY GROUP (00055): Zhang Yushan appointed as the new company secretary.
HK Stock
GLORIOUS PPT H(00845): Property units selling and delivering total construction area exceeding 70,000 square meters in 2025.
HK Stock
SINOMAB BIO-B (03681): The first patient in China with atopic dermatitis completes Phase 2 clinical trial of SM17 treatment.
HK Stock
RECOMMEND
The “Google Panic” In Memory Stocks: New Cycle Dynamics Beneath Technological Headlines
The “Google Panic” In Memory Stocks: New Cycle Dynamics Beneath Technological Headlines
icon
01/04/2026
Price Increase Cycle Begins, Semiconductor Industry Enters New Stage Of Rising Volume And Value
Price Increase Cycle Begins, Semiconductor Industry Enters New Stage Of Rising Volume And Value
icon
01/04/2026
When Will Hong Kong Stocks Reach Their Low Point?
When Will Hong Kong Stocks Reach Their Low Point?
icon
01/04/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.